Skip to content
← Back to this collection

PUBLICATIONS · 25704135

Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: a report from the Children's Oncology Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Pediatr Blood Cancer
Publication date
2015 Apr
First author
Stieglitz E

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Stieglitz E
      type
      Author
    2. name
      Ward AF
      type
      Author
    3. name
      Gerbing RB
      type
      Author
    4. name
      Alonzo TA
      type
      Author
    5. name
      Arceci RJ
      type
      Author
    6. name
      Liu YL
      type
      Author
    7. name
      Emanuel PD
      type
      Author
    8. name
      Widemann BC
      type
      Author
    9. name
      Cheng JW
      type
      Author
    10. name
      Jayaprakash N
      type
      Author
    11. name
      Balis FM
      type
      Author
    12. name
      Castleberry RP
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Stieglitz E
      type
      Author
    2. name
      Ward AF
      type
      Author
    3. name
      Gerbing RB
      type
      Author
    4. name
      Alonzo TA
      type
      Author
    5. name
      Arceci RJ
      type
      Author
    6. name
      Liu YL
      type
      Author
    7. name
      Emanuel PD
      type
      Author
    8. name
      Widemann BC
      type
      Author
    9. name
      Cheng JW
      type
      Author
    10. name
      Jayaprakash N
      type
      Author
    11. name
      Balis FM
      type
      Author
    12. name
      Castleberry RP
      type
      Author
    bibliography ids
    1. nci-bib-de6e523db966b5e0e3b51329
    book metadata
    content sha256
    d5767fd27035b9b8dd86c997e2282076178d694480bf3c2792a8fbadfe9e39b9
    document type
    citation
    dois
    1. 10.1002/pbc.25342
    electronic publication date
    display
    2014 Dec 8
    precision
    day
    year
    2014
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:25704135
    immutable id
    pubmed:25704135@d5767fd27035b9b8dd86c997e2282076178d694480bf3c2792a8fbadfe9e39b9
    journal
    abbreviation
    Pediatr Blood Cancer
    issn electronic
    1545-5017
    issn print
    1545-5009
    issue
    4
    name
    Pediatric blood & cancer
    nlm unique id
    101186624
    pages
    629-36
    volume
    62
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      25704135
      provenance
      batch id
      74265f1b641f04cf2d05
      provider
      NCBI PubMed ESummary
      record sha256
      172dd77bd1176370604074cef0f3d7a687f741884ed28a1bd78a2c22ed8a01a6
      response sha256
      193df6bb6d2ac41af73dc445bf8171fe8076a8c8a5e98882a3d6a1ada428b0f0
      retrieved at
      2026-09-09T23:47:10.134322+00:00
      publication date
      display
      2015 Apr
      precision
      month
      year
      2015
      publication types
      1. Clinical Trial, Phase II
      2. Clinical Trial, Phase III
      3. Journal Article
      4. Multicenter Study
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/25704135/
      title
      Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: a report from the Children's Oncology Group.

      Preserved source evidence · Not medical advice